Deann Thompson
Nurse Practitioner · Ava, MONPI 1508039769
Payments from drug & device makers
Across 104 payments — averaging $16.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$447
- AbbVie$223
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$133
- Amgen$126
- Otsuka America Pharmaceutical, Inc.$116
- Biohaven Pharmaceuticals, Inc.$114
- plus $564 from 11 others
What the payments were for
- Speaking & faculty fees$1016%
- Food & beverage$1,62294%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 20 | $447 |
| AbbVie | 21 | $223 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $133 |
| Amgen | 8 | $126 |
| Otsuka America Pharmaceutical, Inc. | 5 | $116 |
| Biohaven Pharmaceuticals, Inc. | 11 | $114 |
| BD | 4 | $101 |
| Novo Nordisk | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 3 | $57 |
| Pfizer | 3 | $55 |
| Lundbeck LLC | 3 | $53 |
| Merck | 3 | $49 |
| Lilly USA, LLC | 3 | $49 |
| Boehringer Ingelheim | 3 | $48 |
| GSK | 2 | $35 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Exact Sciences | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,723 in reported general payments places this provider in the 80th percentile of 1,898 nurse practitioner providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 116 | $130,747 |
| FarxigaDapagliflozin Propanediol | 114 | $91,683 |
| TrulicityDulaglutide | 86 | $88,107 |
| EliquisApixaban | 83 | $68,181 |
| OzempicSemaglutide | 42 | $55,598 |
| Tresiba Flextouch U-200Insulin Degludec | 34 | $53,976 |
| LinzessLinaclotide | 65 | $53,935 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $44,715 |
| JanuviaSitagliptin Phosphate | 33 | $29,955 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 26 | $27,242 |
| Repatha SureclickEvolocumab | 31 | $25,877 |
| XareltoRivaroxaban | 35 | $25,795 |
| EntrestoSacubitril/Valsartan | 30 | $22,957 |
| JardianceEmpagliflozin | 15 | $20,512 |
| RexultiBrexpiprazole | 11 | $18,772 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $49 | $218,854202 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $447 | $126,218167 claims |
| PfizerEliquis | $55 | $68,18183 claims |
| Novo NordiskOzempic | $77 | $55,59842 claims |
| AbbVieLinzess | $223 | $53,93565 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $35 | $51,91963 claims |
| MerckJanuvia | $49 | $29,95533 claims |
| Boehringer IngelheimJardiance | $48 | $20,51215 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $116 | $18,77211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,898 nurse practitioner providers in Missouri.
Other nurse practitioner in Ava
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
- Courtney JefferyKansas City$24K
- Carrie Roth BettlachSaint Louis$21K
- Amanda HumbersFarmington$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.